Alzheimer's disease (AD) is a progressive irreversible neurodegenerative condition that
typically manifest an irreparable damage to the brain with long-lasting functional impairment.
It has been severely affecting older population worldwide and thus, its early-stage detection
has become a topic of major research interest. Over the past few decades, advances in
neuroimaging research such as positron emission tomography (PET), computed
tomography (CT), magnetic resonance imaging (MRI), fluoro-deoxy-D-glucose (FDG) and …